Abbott Laboratories Past Earnings Performance

Past criteria checks 2/6

Abbott Laboratories has been growing earnings at an average annual rate of 14.5%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 7.2% per year. Abbott Laboratories's return on equity is 14.5%, and it has net margins of 13.9%.

Key information

14.5%

Earnings growth rate

14.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate7.2%
Return on equity14.5%
Net Margin13.9%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Abbott Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:ABL Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2440,3265,60810,5972,651
31 Dec 2340,1095,70110,3852,619
30 Sep 2339,9595,14210,5422,603
30 Jun 2340,2265,14010,5982,724
31 Mar 2341,5055,77910,6302,693
31 Dec 2243,6536,90510,7032,741
30 Sep 2245,0307,85710,9012,921
30 Jun 2245,5488,52010,9712,811
31 Mar 2244,5147,69510,9782,781
31 Dec 2143,0757,04211,0062,738
30 Sep 2142,3087,20810,5932,623
30 Jun 2140,2336,34310,2442,531
31 Mar 2137,3385,6939,8072,441
31 Dec 2034,6084,4499,5912,420
30 Sep 2032,2213,3469,4052,289
30 Jun 2031,4443,0739,4402,305
31 Mar 2032,0953,5399,5972,318
31 Dec 1931,9043,6669,5402,440
30 Sep 1931,3553,2729,4522,395
30 Jun 1930,9352,8679,4032,373
31 Mar 1930,7232,5829,4482,371
31 Dec 1830,5782,3199,5682,298
30 Sep 1830,4028029,4822,280
30 Jun 1829,5758129,1412,274
31 Mar 1828,4453658,8682,219
31 Dec 1727,3903448,8042,183
30 Sep 1725,1341,9718,1751,979
30 Jun 1723,6071,0557,8081,763
31 Mar 1722,3031,3847,3951,575
31 Dec 1620,8531,0566,5581,442
30 Sep 1620,7089896,6201,353
30 Jun 1620,5561,9396,6581,379
31 Mar 1620,3932,1246,6481,392
31 Dec 1520,4052,5866,7421,371
30 Sep 1520,5732,5236,5931,338
30 Jun 1520,5022,3656,5221,265
31 Mar 1520,3892,0046,4441,230
31 Dec 1420,2471,7106,3271,286
30 Sep 1419,9051,5606,3731,343
30 Jun 1419,6511,7626,3901,377
31 Mar 1419,0341,6546,1741,394
31 Dec 1319,6571,9706,3401,371
30 Sep 1320,2759616,6981,472
30 Jun 1320,7156486,8881,483

Quality Earnings: ABL has high quality earnings.

Growing Profit Margin: ABL's current net profit margins (13.9%) are lower than last year (13.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ABL's earnings have grown by 14.5% per year over the past 5 years.

Accelerating Growth: ABL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ABL had negative earnings growth (-3%) over the past year, making it difficult to compare to the Medical Equipment industry average (-9.8%).


Return on Equity

High ROE: ABL's Return on Equity (14.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.